tirzepatide weight loss fort collins GLP-1 Medication Collins, CO GLP-1 Therapy for Weight Loss

The effect of metformin and standard therapy versus standard therapy alone in nondiabetic patients with insulin resistance and nonalcoholic steatohepatitis (NASH): A pilot trial

before anything is dispensed

AOD-9604 is not going to produce 20 percent body weight reductions

About Roundhill GLP-1 & Weight Loss ETF (NASDAQ:OZEM) Key Stats Today's Range $32.42 $32.62 50-Day Range $29.78 $33.99 52-Week Range $23.22 $37.15 Volume 8,549 shs Average Volume 25,992 shs Market Capitalization $62.69 million Assets Under Management N/A Dividend Yield N/A Net Expense Ratio 0.59% Aggregate Rating Moderate Buy ETF Overview Roundhill GLP-1 & Weight Loss ETF Expenses Receive OZEM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Roundhill GLP-1 & Weight Loss ETF and its competitors with MarketBeat's FREE daily newsletter